News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
LeCointe-Cephas Lisa
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2023 |
4
| LeCointe-Cephas Lisa (SVP Chief Ethics & Com Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 9,682 options to buy
@ $117.89, valued at
$1.1M
Granted 1,781 restricted stock units
@ $0 |
|
| 05/03/2023 |
4
| LeCointe-Cephas Lisa (SVP Chief Ethics & Com Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 643 shares
@ $115.47, valued at
$74.2k
Paid exercise price by delivering 221 shares
@ $115.47, valued at
$25.5k
Exercised 643 restricted stock units
@ $0 |
|
| 05/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| LeCointe-Cephas Lisa (SVP Chief Ethics & Com Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 452 shares
@ $87.65, valued at
$39.6k
Paid exercise price by delivering 155 shares
@ $87.65, valued at
$13.6k
Exercised 452 restricted stock units
@ $0 |
|
| 05/03/2022 |
4
| LeCointe-Cephas Lisa (SVP Chief Ethics & Com Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 640 shares
@ $88.69, valued at
$56.8k
Paid exercise price by delivering 220 shares
@ $88.69, valued at
$19.5k
Exercised 640 restricted stock units
@ $0 |
|
| 05/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/07/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|